Harrow Health Inc. 8.625% Senior Notes due 2026

HROWL | NASDAQ

Price Alert Chart Builder DCF Calculator

$25.61

+$0.05 (+0.19%)

At close: undefined

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

0.19%

(1Y)

Key Statistics

Market Data

Market Cap $1.37B

1D Range

25.53 25.63

52W Range

25 25.72

Valuation (TTM)

PE -

PB N/A

EV/EBITDA N/A

Valuation (NTM)

Forward PE N/A

Forward PEG N/A

Price Target N/A

Cash Flow

FCF Yield N/A

SBC Adj. FCF Yield N/A

SBC Impact N/A

Margins

Gross Margin N/A

Operating Margin N/A

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y N/A | N/A

FCF 3Y | 5Y N/A | N/A

Returns

ROA N/A

ROE N/A

ROIC N/A

Financial Health

Net Debt

Current Ratio N/A

Interest Coverage N/A

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Harrow, Inc. engages in the development, production, and sale of innovative medications. It operates through the following segments: Pharmaceutical Compounding and Pharmaceutical Drug Development. The...

Sector Healthcare

Industry Medical - Pharmaceuticals

Employees 217

IPO Date May 6, 2021

Website www.harrowinc.com

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.